These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12074699

  • 1. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids.
    Dueñas-Carrera S, Alvarez-Lajonchere L, César Alvarez-Obregón J, Pérez A, Acosta-Rivero N, Vázquez DM, Martínez G, Viña A, Pichardo D, Morales J.
    Biotechnol Appl Biochem; 2002 Jun; 35(3):205-12. PubMed ID: 12074699
    [Abstract] [Full Text] [Related]

  • 2. Immunization with a DNA vaccine encoding the hepatitis-C-virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab-eating macaque monkeys).
    Dueñas-Carrera S, Viña A, Martínez R, Alvarez-Lajonchere L, Alvarez-Obregón JC, Marante J, Pérez A, Mosqueda O, Martínez G, Morales J.
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):249-55. PubMed ID: 15032746
    [Abstract] [Full Text] [Related]

  • 3. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J, Murata K, Lechmann M, Manickan E, Zhang Z, Wedemeyer H, Rehermann B, Liang TJ.
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice.
    Alvarez-Lajonchere L, González M, Alvarez-Obregón JC, Guerra I, Viña A, Acosta-Rivero N, Musacchio A, Morales J, Dueñas-Carrera S.
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):9-17. PubMed ID: 16367740
    [Abstract] [Full Text] [Related]

  • 5. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS, Zhao P, Cao J, Yu JP, Qi ZT.
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [Abstract] [Full Text] [Related]

  • 6. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode.
    Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J, Fournillier A, De Martynoff G, Trepo C, Inchauspe G.
    J Virol; 1997 Sep; 71(9):7101-9. PubMed ID: 9261444
    [Abstract] [Full Text] [Related]

  • 7. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.
    Fournillier A, Depla E, Karayiannis P, Vidalin O, Maertens G, Trépo C, Inchauspé G.
    J Virol; 1999 Sep; 73(9):7497-504. PubMed ID: 10438839
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice.
    Ghorbani M, Nass T, Azizi A, Soare C, Aucoin S, Giulivi A, Anderson DE, Diaz-Mitoma F.
    Viral Immunol; 2005 Sep; 18(4):637-48. PubMed ID: 16359230
    [Abstract] [Full Text] [Related]

  • 9. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM, Ezelle H, Shah S, Barber GN.
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [Abstract] [Full Text] [Related]

  • 10. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
    Forns X, Emerson SU, Tobin GJ, Mushahwar IK, Purcell RH, Bukh J.
    Vaccine; 1999 Apr 09; 17(15-16):1992-2002. PubMed ID: 10217599
    [Abstract] [Full Text] [Related]

  • 11. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G.
    Virology; 2000 Oct 25; 276(2):259-70. PubMed ID: 11040118
    [Abstract] [Full Text] [Related]

  • 12. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.
    Vaccine; 2011 May 09; 29(20):3714-23. PubMed ID: 21396407
    [Abstract] [Full Text] [Related]

  • 13. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
    Zhu LX, Liu J, Ye Y, Xie YH, Kong YY, Li GD, Wang Y.
    World J Gastroenterol; 2004 Sep 01; 10(17):2488-92. PubMed ID: 15300890
    [Abstract] [Full Text] [Related]

  • 14. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y, Min YQ, Liu M, Chi L, Zhao P, Zhang XL.
    Biochim Biophys Acta; 2016 Aug 01; 1860(8):1764-75. PubMed ID: 26278021
    [Abstract] [Full Text] [Related]

  • 15. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
    Alvarez-Lajonchere L, Amador-Cañizares Y, Frías R, Milian Y, Musacchio A, Guerra I, Acosta-Rivero N, Martínez G, Castro J, Puentes P, Cosme K, Dueñas-Carrera S.
    Biotechnol Appl Biochem; 2008 Oct 01; 51(Pt 2):97-105. PubMed ID: 18215116
    [Abstract] [Full Text] [Related]

  • 16. Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes.
    Fournillier A, Nakano I, Vitvitski L, Depla E, Vidalin O, Maertens G, Trépo C, Inchauspé G.
    Hepatology; 1998 Jul 01; 28(1):237-44. PubMed ID: 9657118
    [Abstract] [Full Text] [Related]

  • 17. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization.
    Inchauspe G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C.
    DNA Cell Biol; 1997 Feb 01; 16(2):185-95. PubMed ID: 9052739
    [Abstract] [Full Text] [Related]

  • 18. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H, Maghraby AS, Solliman Mel-D, El-Mokadem MT, Sherif MM, Arafa A, Bahgat MM.
    Arch Virol; 2015 Apr 01; 160(4):945-58. PubMed ID: 25631616
    [Abstract] [Full Text] [Related]

  • 19. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J.
    Hepatology; 2000 Sep 01; 32(3):618-25. PubMed ID: 10960458
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L, Shoukry NH, Grá B, Amador-Cañizares Y, Helle F, Bédard N, Guerra I, Drouin C, Dubuisson J, González-Horta EE, Martínez G, Marante J, Cinza Z, Castellanos M, Dueñas-Carrera S.
    J Viral Hepat; 2009 Mar 01; 16(3):156-67. PubMed ID: 19017255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.